Direct oral anticoagulants have recently emerged as an attractive choice for patients
requiring anticoagulation treatment. They have a rapid onset of action and can be …

In the pivotal randomized controlled trials (RCTs) for patients with atrial fibrillation, direct oral
anticoagulants (DOACs) had similar or even superior efficacy and safety compared with …

Although warfarin has been the “king” of oral anticoagulation for the past few decades, its
reign is now jeopardized by the recent marketing in Canada of 3 new oral anticoagulants …

In recent years, small oral compounds that specifically block activated coagulation factor X
(FXa) or thrombin (FIIa) have become alternatives to the anticoagulants that had been used …

Direct oral anticoagulants (DOACs) are approved for multiple thromboembolic disorders and
provide advantages over existing agents. As with all anticoagulants, management protocols …

Preview The overall prescription of oral anticoagulants has steadily increased as important
randomized clinical trials have clarified various indications for therapy. However, a number …

Background Direct oral anticoagulants (DOACs) are the treatment of choice for most patients
with atrial fibrillation and/or noncancer-associated venous thromboembolic disease …

New oral anticoagulants: dosing and monitoring Page 1 GASTROINTESTINAL BLEEDING
AND ORAL ANTICOAGULANTS New oral anticoagulants: dosing and monitoring Jignesh P …

In recent years, several direct‐acting oral anticoagulants (DOAC) have become available for
use in Europe and other regions in indications related to prophylaxis and treatment of …

The direct oral anticoagulants (DOACs) are recommended as the first-choice anticoagulants
for both stroke prevention in patients with non-valvular atrial fibrillation and the treatment …